| Entry |
|
|---|
| Name |
Bretazenil (USAN/INN) |
|---|
| Formula |
C19H20BrN3O3
|
|---|
| Exact mass |
417.0688
|
|---|
| Mol weight |
418.28
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
|
|---|
| Efficacy |
Antianxiety |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D03155 Bretazenil
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D03155 Bretazenil (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C8y C 24.2878 -16.0378
2 N4y N 25.5353 -15.4094
3 C8y C 26.8121 -15.9871
4 C1y C 27.1526 -17.3358
5 C8y C 24.0069 -17.4193
6 N1y N 26.3105 -18.4585
7 C5x C 24.9087 -18.4919
8 C1x C 27.1184 -19.6062
9 C1x C 28.4593 -19.1928
10 C1x C 28.4805 -17.7895
11 C8x C 23.2385 -15.1096
12 C8x C 21.9101 -15.5544
13 C8x C 21.6292 -16.9359
14 C8y C 22.6786 -17.8640
15 C8y C 27.7560 -14.9511
16 N5x N 27.0626 -13.7334
17 C8x C 25.6901 -14.0167
18 O5x O 24.3436 -19.7442
19 X Br 22.3997 -19.2354
20 C7a C 29.1349 -14.9642
21 O7a O 29.7164 -13.6902
22 O6a O 29.8216 -16.1745
23 C1d C 31.1174 -13.6902
24 C1a C 32.5182 -13.6902
25 C1a C 31.1178 -12.2579
26 C1a C 31.1170 -15.0595
BOND 29
1 3 4 1
2 1 5 1
3 2 3 1
4 5 7 1
5 1 2 1
6 6 7 1
7 6 4 1
8 6 8 1
9 8 9 1
10 9 10 1
11 4 10 1
12 1 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 5 14 2
17 3 15 2
18 15 16 1
19 16 17 2
20 2 17 1
21 7 18 2
22 14 19 1
23 15 20 1
24 20 21 1
25 20 22 2
26 21 23 1
27 23 24 1
28 23 25 1
29 23 26 1
|
|---|